Entering text into the input field will update the search result below

Global Blood Therapeutics up 18% after report on buyout interest

Aug. 04, 2022 6:33 AM ETPfizer Inc. (PFE)By: Dulan Lokuwithana, SA News Editor5 Comments

word m and a made with wood building blocks, stock image

Maks_Lab/iStock via Getty Images

  • Global Blood Therapeutics (NASDAQ:GBT), a drug maker targeting sickle cell disease (SCD), continues to trade higher in the pre-market Thursday with a gain of ~18% after Bloomberg reported that the company is drawing takeover interest.
  • Some large

Recommended For You

Comments (5)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

Pfizer, according to news.
I’m sure they will sell at the exact wrong time.
joezapp profile picture
Seems like we may finally get true value for our investment!
Tobias_Funke profile picture
NOVO makes good sense here.
Vikdan profile picture
@Tobias_Funke Agreed, Novo could certainly be a buyer
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.